Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
Mário Rodrigues Louzã1, Helio Elkis1, Sandra Ruschel2, Irismar Reis de Oliveira3, Rodrigo Affonseca Bressan4, Paulo Belmonte-de-Abreu5, Hamilton Grabowski6, José Carlos Appolinário71Universidade de São Paulo, S&atilde...
Guardado en:
Autores principales: | Louzã M, Elkis H, Ruschel S, de Oliveira IR, Bressan RA, Belmonte-de-Abreu P, Grabowski H, Appolinário JC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ac65a0cc429c475dafe29be5121d1ee8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
por: Mario Louzã, et al.
Publicado: (2010) -
Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia
por: Gordon PC, et al.
Publicado: (2013) -
Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
por: Olivares JM, et al.
Publicado: (2013) -
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Adel Gabriel
Publicado: (2010) -
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Anna Kelemen, et al.
Publicado: (2010)